N-Acetyl Cysteine as an Add-on Therapy is Useful in Treating Acute Lumbar Radiculopathy Caused by Disc Herniation: Results of a Randomized, Controlled Clinical Trial

CONCLUSIONS: This study suggested that NAC might be a relevant candidate for adjunct therapy in managing acute lumbar radiculopathy. Additional clinical trials are needed to validate these findings.TRIAL REGISTRATION: The trial was registered at Clinicaltrials.gov (identifier code: IRCT2012021 5009014N381). Registration date: 2021-02-06.PMID:37779397 | DOI:10.2174/0115748871250545230919055109

Source: Reviews on Recent Clinical Trials - October 2, 2023 Category: Cancer & Oncology Authors: Bijan Heidari Zeinab-Alsadat Seyedian Maryam Mehrpooya Davoud Ahmadimoghaddam Mahtabalsadat Mirjalili Masood Ghiasian Source Type: research